Facebook
Twitterhttps://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.
Facebook
Twitterhttps://www.bccresearch.com/aboutus/terms-conditionshttps://www.bccresearch.com/aboutus/terms-conditions
BCC Research Market Analyst says global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a CAGR of 9.8%.
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The global sales of homecare medical devices are estimated to be worth USD 172.6 billion in 2025 and are anticipated to reach a value of USD 403.4 billion by 2035.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 158.5 billion |
| Estimated Size, 2025 | USD 172.6 billion |
| Projected Size, 2035 | USD 403.4 billion |
| Value-based CAGR (2025 to 2035) | 8.9% |
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 9.6% (2024 to 2034) |
| H2 | 9.3% (2024 to 2034) |
| H1 | 8.9% (2025 to 2035) |
| H2 | 8.4% (2025 to 2035) |
Country-wise Insights
| Country | Value CAGR (2025 to 2035) |
|---|---|
| United States | 2.3% |
| Germany | 2.0% |
| Italy | 2.5% |
| UK | 4.6% |
| India | 7.3% |
| China | 6.8% |
Category-wise Insights
| Product | Value Share (2025) |
|---|---|
| Wheelchairs | 57.4% |
| By Distribution Channel | Value Share (2025) |
|---|---|
| Online Retailers | 39.5% |
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Report Covers Global Smart Medical Devices Market Size & Trends and It is Segmented by Product Type (Diagnostic and Monitoring and Therapeutic Devices), End User (Hospitals/Clinics, Home-Care Setting, and More), by Connectivity (Bluetooth, Wi-Fi, and More), by Distribution Channel (Offline and Online), and Geography. The Market Provides the Value (in USD Million) for the Above Segments.
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Medical Devices Reimbursement Market Report is Segmented by Payer (Public and Private), Healthcare Settings (Hospitals, Outpatients Facilities, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Provides the Value (in USD) for the Above-Mentioned Segments.
Facebook
Twitterhttps://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html
Pediatric Medical Devices Market Snapshot
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 27.6 Bn |
| Market Forecast (Value) in 2031 | US$ 47.4 Bn |
| Growth Rate (CAGR) | 6.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Facebook
Twitterhttps://www.marknteladvisors.com/privacy-policyhttps://www.marknteladvisors.com/privacy-policy
The UAE Medical Device Market size was valued at around USD 1.92 billion in 2023 and is estimated to grow at a CAGR of about 8.87% during the forecast period, i.e., 2024-30.
Facebook
Twitterhttps://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Market Size statistics on the Medical Device Manufacturing industry in the US
Facebook
TwitterIn 2021, the AI and machine learning medical device market was valued at around *** billion U.S. dollars globally. By 2032, the market was forecast to increase to a value of **** billion U.S. dollars.
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
In the coming years the Asia Pacific reprocessed medical devices market is expected to reach USD 480.7 million by 2025 and is expected to steadily grow at a CAGR of 5.7% to reach USD 833.5 million by 2035. In 2024, cluster headache syndrome generated roughly USD 457.1 million in revenues.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 480.7 million |
| Industry Value (2035F) | USD 833.5 million |
| CAGR (2025 to 2035) | 5.7% |
Country Wise Analysis
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 7.6% |
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 3.3% |
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.6% |
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 8.1% |
| Country | CAGR (2025 to 2035) |
|---|---|
| Australia | 2.9% |
Competitive Outlook
| Company Name | Estimated Market Share (%) |
|---|---|
| Stryker Corporation | (17-18)% |
| Medline Industries, Inc. | (14-15)% |
| Johnson & Johnson (Ethicon) | (11-12)% |
| Medtronic plc | (10-11)% |
| Other Companies (combined) | (43-44)% |
Facebook
Twitterhttps://www.imarcgroup.com/privacy-policyhttps://www.imarcgroup.com/privacy-policy
The global implantable medical devices market size reached USD 141.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 209.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of chronic diseases, increasing demand for smaller, more advanced implantable medical devices, and growing integration of digital health technologies and connectivity features in implantable devices are some of the key factors driving the growth of the market.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2024
|
|
Forecast Years
|
2025-2033
|
|
Historical Years
|
2019-2024
|
|
Market Size in 2024
| USD 141.3 Billion |
|
Market Forecast in 2033
| USD 209.1 Billion |
| Market Growth Rate 2025-2033 | 4.5% |
IMARC Group provides an analysis of the key trends in each segment of the global implantable medical devices market report, along with forecasts at the global and regional levels from 2025-2033. Our report has categorized the market based on product type, material and end-user.
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
According to Future Market Insights research, during the projected period, the global medical device analytical testing outsourcing market is expected to expand at a CAGR of 6.4%. The industry value is projected to increase from USD 5,844 million in 2024 to USD 10,867.3 million by 2034. The industry was valued at USD 5,492.40 million at the end of 2023.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 5,492.40 million |
| Estimated Size, 2024 | USD 5,844 million |
| Projected Size, 2034 | USD 10,867.3 million |
| Value-based CAGR (2024 to 2034) | 6.4% |
Semi Annual Market Update
| Particulars | Value CAGR |
|---|---|
| H1 | 7.4% (2023 to 2033) |
| H2 | 7.1% (2023 to 2033) |
| H1 | 6.4% (2024 to 2034) |
| H2 | 5.9% (2024 to 2034) |
Country-wise Insights
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| India | 8.8% |
| Spain | 4.3% |
| The United States | 3.6% |
| Canada | 3.8% |
Category-wise Insights
| Service | Extractable and Leachable (E&L) Testing |
|---|---|
| Value Share (2024) | 26.15% |
| End Use | Medical Device Analytical Testing Outsourcing |
|---|---|
| Value Share (2024) | 81.5% |
Facebook
Twitterhttps://www.astuteanalytica.com/privacy-policyhttps://www.astuteanalytica.com/privacy-policy
Europe Medical Devices Market is projected to reach USD 305.01 billion by 2033, growing at a CAGR of 5.0% from 2025-2033.
Facebook
TwitterIn 2024, Germany held the largest share of the medical device market in Europe. Standing at 25.2 percent, the German medical device industry had a higher share than the next two competitors, France and the United Kingdom, added together.
Facebook
Twitterhttps://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The size of the Medical Device Connectivity Industry market was valued at USD 3.16 Million in 2023 and is projected to reach USD 14.04 Million by 2032, with an expected CAGR of 23.74% during the forecast period. Recent developments include: July 2022: Abbott announced that it received United States Food and Drug Administration breakthrough device designation for its deep brain stimulation (DBS) system., March 2022: Cognosos, Inc., a leading Real-Time Location Services (RTLS) provider, launched LocationAI, a highly accurate, machine learning-powered location engine, into its asset-tracking platform for hospitals and healthcare facilities.. Key drivers for this market are: Rising Implementation of Electronic Health Records and Health Information Exchange Systems, Increase in the Demand for Telehealth and Telemedicine Technologies; Technological Advancements in Wireless Technologies and Bluetooth-Enabled Medical Devices. Potential restraints include: High Cost of Deployment and Complete Installation Limiting the Adoption of Advanced Solutions, Data Privacy and Security Concerns. Notable trends are: Wireless Technologies Segment by Technology is Expected to Witness a Significant Growth over the Forecast Period.
Facebook
Twitterhttps://www.gmiresearch.com/terms-and-conditions/https://www.gmiresearch.com/terms-and-conditions/
Saudi Arabia Medical Device Market size reached USD 6.3 billion in 2024 and is expected to touch USD 9.6 billion in 2032, expanding at a CAGR of 5.5% till 2032
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Self Care Medical Devices Market is Segmented by Type (Blood Glucose Monitors, Blood Pressure Monitors, Body Temperature Monitors, Nebulizers, Pedometers, Pregnancy/Fertility Test Kits, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.
Facebook
Twitterhttps://www.rootsanalysis.com/privacy.htmlhttps://www.rootsanalysis.com/privacy.html
The medical device contract manufacturing market size is predicted to reach from USD 78.8 billion in 2024 to USD 126.4 billion by 2030, with a noteworthy CAGR of 8.2%
Facebook
TwitterIn 2023, the medical device market was worth approximately *** billion U.S. dollars in the United States. Throughout the time interval, the revenue in the medical device market increased year-on-year, except for the pandemic-affected 2020.
Facebook
Twitterhttps://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
The global medical device design service market exceeded USD million in 2023 and is projected to register a CAGR during the forecast period. Increasing demand for advanced and innovative medical devices, coupled with the rising prevalence of chronic diseases, is fueling the market growth. Furthermore, the growing need to streamline the medical device design and development process, adhere to stringent regulatory requirements, and reduce time-to-market is driving the demand for medical device design services. Key trends shaping the medical device design service market include the increasing adoption of computer-aided design (CAD) and computer-aided manufacturing (CAM) technologies, which enhance design precision and efficiency. Additionally, the growing emphasis on user-centric design and personalized medical devices is driving the demand for design services that cater to specific patient needs. However, factors such as regulatory complexities and intellectual property concerns may restrain market growth to some extent. The Medical Device Design Service market is a highly fragmented but rapidly growing industry, with an estimated market size of over $30 billion in 2023. It is expected to grow at a CAGR of over 6% during the forecast period (2023-2028). This report provides a comprehensive overview of the industry, including an analysis of major trends, growth drivers, and challenges.
Facebook
Twitterhttps://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.